Vardaman v. Baker Center, Inc.

711 So. 2d 727, 1998 WL 148822
CourtLouisiana Court of Appeal
DecidedMarch 13, 1998
Docket96 CA 2611
StatusPublished
Cited by29 cases

This text of 711 So. 2d 727 (Vardaman v. Baker Center, Inc.) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vardaman v. Baker Center, Inc., 711 So. 2d 727, 1998 WL 148822 (La. Ct. App. 1998).

Opinion

711 So.2d 727 (1998)

Lyle VARDAMAN, et ux., Harold Turner, et ux., Ernie Pierce, et ux., Lester Berry, individually and on behalf of Jory Berry, Elizabeth Berry, and Susan Crowe
v.
BAKER CENTER, INC. and Velsicol Chemical Company.

No. 96 CA 2611.

Court of Appeal of Louisiana, First Circuit.

March 13, 1998.

*728 Kevin Patrick Monahan, Baton Rouge, for Plaintiffs-Appellant Lyle Vardaman, et al.

J. Thaddeus Westholz, Diane Kathleen O'Hara, Hulse and Wanek, New Orleans, for Defendant-Appellee Baker Center, Inc.

Amos H. Davis, Smith and Davis, Baton Rouge, for Defendant-Appellee Interstate Fire and Casualty Company.

Michael G. Durand, Gary P. Kraus, Onebane, Bernard, Tortan, Diaz, McNamara and Abell, Lafayette, for Defendant-Appellee Willie's Exterminating Company.

Before GONZALES and PARRO, JJ., and TYSON, J. Pro Tem.[1]

PARRO, Judge.

This is an appeal from the trial court's judgment, granting motions for summary judgment in favor of all defendants and dismissing plaintiffs' claims that they suffered mental and physical health problems as a result of exposure to chlordane. We affirm.

FACTUAL AND PROCEDURAL HISTORY

The plaintiffs in this case include Lyle and Irma Lewis Vardaman, Lyle Vardaman on behalf of his minor son, James Lutrick Vardaman,[2] Harold and Juanita Turner, Ernie and Jane Pierce, Lester and Elizabeth Berry, Lester Berry on behalf of his minor son, Jory Scott Berry, and Susan Crowe. They allege that Irma Lewis Vardaman, Juanita Turner, Ernie Pierce, Lester Berry, Elizabeth Berry, Jory Scott Berry, and Susan Crowe all worked at a furniture store when the building was treated with a pesticide containing chlordane. They claim their exposure to this chemical caused them various mental and physical health problems and caused their families to experience loss of consortium.

In August 1988, the plaintiffs sued Baker Center, Inc. (Baker Center), the owner of the furniture store premises, and Velsicol Chemical Company (Velsicol), the manufacturer of the pesticide. Willie's Exterminating Company (Willie's), the company which treated the premises for termites, and Interstate Fire and Casualty Insurance Company (Interstate), the liability insurer of Willie's, were added as defendants in a supplemental and amending petition.[3]

The case had been pending for over five years when, in March 1994, Velsicol filed requests for admissions. Among other things, these asked plaintiffs to admit that 1) no doctor had opined their chlordane exposure was sufficient to cause any physical or mental injury, 2) they had no evidence proving exposure to chlordane in sufficient quantities to cause injury, and 3) they had no *729 evidence establishing any of their physical or mental problems were caused by exposure to chlordane. The plaintiffs did not answer or object to any of the requests for admissions for over a year.

In July 1995, Velsicol moved for summary judgment on the basis that the above facts were deemed admitted because the plaintiffs had not responded to its requests for admissions. The motion alleged that, given these admitted facts, the plaintiffs could not support their claims that exposure to chlordane caused their injuries. The other defendants then filed similar motions for summary judgment, and all motions were set for hearing. The day before the hearing, the plaintiffs moved for a continuance, claiming additional time was needed to get affidavits from medical experts who had treated or tested them. Attached to the motion were uncertified copies of medical reports, letters from physicians, and unverified lab test results. The trial court granted a thirty-day continuance. The day before the re-scheduled hearing, the plaintiffs answered the requests for admissions, denying the statements upon which the motions for summary judgment were based. Also, although the plaintiffs did not submit affidavits from any medical experts at the hearing and did not file them into the record at this time, certain affidavits were apparently made available to opposing counsel, along with the denials of the requests for admissions.[4]

At the hearing, because of the plaintiffs' late responses to the requests for admissions, the court allowed Willie's an additional ten days to provide a supplemental memorandum in support of its motion for summary judgment. Willie's filed an additional memorandum and attached the affidavit of Dr. Michael James Wernke, a toxicologist/pharmacologist. Dr. Wernke had reviewed the plaintiffs' petitions and available medical records and lab test results, along with affidavits from physicians who had examined the plaintiffs. He cited studies showing that the general population in the United States has detectable levels of chlordane-related substances in blood and adipose tissue because of its presence in air, food, and water from numerous sources. Based on the lab test results submitted by the plaintiffs, Dr. Wernke noted that the concentrations of chlordane-related chemicals shown in their body tissues were below or within the levels reported for the general United States population who had not experienced an unusual environmental or occupational exposure to chlordane. Because of this, Dr. Wernke concluded that neither the plaintiffs nor their experts could pinpoint the source of their exposures with any degree of scientific or medical certainty. Most significantly, he stated the concentrations of these substances in the plaintiffs' blood and adipose tissue samples had not been shown in the medical and scientific literature to cause adverse health effects.

Dr. Wernke's affidavit referred to affidavits from plaintiffs' experts, which he obviously had reviewed. However, these affidavits were not in the record until several months after the hearing, when they were filed by plaintiffs' counsel in an "appearance filing" while the motions were still under advisement.

The trial court did not grant the motions on the basis of the facts deemed admitted by virtue of the plaintiffs' failure to respond timely to Velsicol's requests for admissions. Rather, the court reviewed the affidavits and other evidence submitted by the parties after the hearing. Based on this evidence, the court granted the motions for summary judgment and dismissed all of plaintiffs' claims against the defendants, finding that:

[T]he plaintiffs did not submit sufficient expert testimony to show that the claimed damages were a result of the chlordane exposure they claim occurred at the Baker Center. The Court does not believe that the evidence submitted by the plaintiffs *730 meets the test set forth in Foret and Daubert. In addition, the affidavit of Dr. Wernke establishes that plaintiffs' (sic) cannot show a causal connection between the alleged injuries and an exposure to chlordane. Also, plaintiffs' experts have ignored other alternative explanations for the alleged symptoms.

The judgment was signed on February 13, 1996, and this appeal followed.

The plaintiffs contend the trial court erred in determining they did not submit sufficient expert testimony and in improperly weighing affidavits as to the medical evidence of causation between chlordane exposure and plaintiffs' injuries. In support of this claim, they argue the court should not have allowed the defendants to present an expert's affidavit "ex post facto," addressed to the inadequacy of the plaintiffs' experts' conclusions and lack of scientific methodology.

ANALYSIS

Summary Judgment Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Serita Devone Millican v. Tevin Kadeem Wade
Louisiana Court of Appeal, 2024
Ivy v. Tran
E.D. Louisiana, 2021
Kathie and Joe Boyer v. Kai Morimoto, MD and Plastic Surgery Northwest
449 P.3d 285 (Court of Appeals of Washington, 2019)
Danos Tree Serv., LLC v. Proride Trailers, LLC
255 So. 3d 1078 (Louisiana Court of Appeal, 2018)
Gauthier v. Harmony Construction, LLC
128 So. 3d 314 (Louisiana Court of Appeal, 2013)
Lopez v. Thibodeaux
28 So. 3d 1215 (Louisiana Court of Appeal, 2010)
Troy A. Lopez v. Glenn A. Thibodeaux
Louisiana Court of Appeal, 2010
Joffrion v. Ferguson
5 So. 3d 1060 (Louisiana Court of Appeal, 2009)
DAN-CIN CONST. CO., INC. v. Thrasher
9 So. 3d 205 (Louisiana Court of Appeal, 2009)
City of Baton Rouge v. Am. Home Assur. Co.
991 So. 2d 48 (Louisiana Court of Appeal, 2008)
Devall v. Baton Rouge Fire Department
979 So. 2d 500 (Louisiana Court of Appeal, 2007)
Hall v. Our Lady of the Lake RMC
968 So. 2d 179 (Louisiana Court of Appeal, 2007)
Denton v. Vidrine
947 So. 2d 850 (Louisiana Court of Appeal, 2006)
Franklin v. Franklin
928 So. 2d 90 (Louisiana Court of Appeal, 2005)
Phelps Dunbar, LLP v. Stout
914 So. 2d 44 (Louisiana Court of Appeal, 2005)
Kinkle v. RDC, LLC
889 So. 2d 405 (Louisiana Court of Appeal, 2004)
Mary J. Kinkle v. R.D.C., LLC
Louisiana Court of Appeal, 2004

Cite This Page — Counsel Stack

Bluebook (online)
711 So. 2d 727, 1998 WL 148822, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vardaman-v-baker-center-inc-lactapp-1998.